D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −3,098−100.0% | Sold out | Holders |
| Q4 2023 | 3,098 | $593.0K | <0.1% | −192−5.8% | Reduced | Holders |
| Q3 2023 | 3,290 | $582.7K | <0.1% | +57+1.8% | Added | Holders |
| Q2 2023 | 3,233 | $614.1K | <0.1% | +20+0.6% | Added | Holders |
| Q1 2023 | 3,213 | $643.6K | <0.1% | −36−1.1% | Reduced | Holders |
| Q4 2022 | 3,249 | $772.1K | <0.1% | +273+9.2% | Added | Holders |
| Q3 2022 | 2,976 | $596.0K | <0.1% | −1,105−27.1% | Reduced | Holders |
| Q2 2022 | 4,081 | $595.0K | <0.1% | +100+2.5% | Added | Holders |
| Q1 2022 | 3,981 | $650.0K | <0.1% | −248−5.9% | Reduced | Holders |
| Q4 2021 | 4,229 | $717.0K | <0.1% | +187+4.6% | Added | Holders |
| Q3 2021 | 4,042 | $763.0K | <0.1% | +171+4.4% | Added | Holders |
| Q2 2021 | 3,871 | $656.0K | <0.1% | +246+6.8% | Added | Holders |
| Q1 2021 | 3,625 | $512.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.